Are we solving obesity while quietly worsening muscle loss?
Over the past three years, few therapeutic categories have reshaped the healthcare landscape as...
"Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: ...
.jpg?width=365&name=dieticians%20Metabolic%20Baloance%202%20(1).jpg)
Metabolic Balance® is a personalised nutrition and metabolic management program developed in...
Glucagon-like peptide-1 (GLP-1) receptor agonists — including Ozempic (semaglutide), Wegovy...
The aesthetic industry is evolving.
The aesthetic industry has long been defined by innovation — new injectables, advanced devices, and...
.jpg?width=365&name=411987b45da8572140dcbd651972774d5bead396-16x9-x0y510w4807h2704%20(1).jpg)
Ozempic and GLP-1 therapies are transforming weight management conversations across healthcare.
GLP-1 agonist medications have rapidly become the dominant medical response to obesity and weight...
In the past few years, glucagon-like peptide-1 (GLP-1) drugs such as semaglutide and tirzepatide...